CN102770421B - 作为药物和诊断组合物的载体的冠醚的原酸酯衍生物 - Google Patents
作为药物和诊断组合物的载体的冠醚的原酸酯衍生物 Download PDFInfo
- Publication number
- CN102770421B CN102770421B CN201080062354.9A CN201080062354A CN102770421B CN 102770421 B CN102770421 B CN 102770421B CN 201080062354 A CN201080062354 A CN 201080062354A CN 102770421 B CN102770421 B CN 102770421B
- Authority
- CN
- China
- Prior art keywords
- groups
- group
- crown ether
- crown
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09014693A EP2332929A1 (en) | 2009-11-25 | 2009-11-25 | Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions |
| EP09014693.7 | 2009-11-25 | ||
| PCT/EP2010/068224 WO2011064300A1 (en) | 2009-11-25 | 2010-11-25 | Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102770421A CN102770421A (zh) | 2012-11-07 |
| CN102770421B true CN102770421B (zh) | 2014-11-26 |
Family
ID=42101959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201080062354.9A Expired - Fee Related CN102770421B (zh) | 2009-11-25 | 2010-11-25 | 作为药物和诊断组合物的载体的冠醚的原酸酯衍生物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8624044B2 (enExample) |
| EP (2) | EP2332929A1 (enExample) |
| JP (1) | JP5848708B2 (enExample) |
| CN (1) | CN102770421B (enExample) |
| AU (1) | AU2010323101B2 (enExample) |
| BR (1) | BR112012012539B8 (enExample) |
| CA (1) | CA2783306C (enExample) |
| ES (1) | ES2557916T3 (enExample) |
| IL (1) | IL219966A (enExample) |
| WO (1) | WO2011064300A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102770152B (zh) | 2009-11-25 | 2016-07-06 | 阿瑞斯根股份有限公司 | 肽类的粘膜递送 |
| EP2526971A1 (en) * | 2011-05-25 | 2012-11-28 | ArisGen SA | Mucosal delivery of drugs |
| EP3000811B1 (en) | 2014-09-24 | 2017-11-08 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Crown Ether Complexes and Methods for Poducing the Same |
| WO2020074691A1 (en) * | 2018-10-12 | 2020-04-16 | Advanced Accelerator Applications International Sa | Pharmaceutical composition comprising a radiolabeled gprp antagonist and a surfactant |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1905454A1 (en) * | 2006-09-27 | 2008-04-02 | Paolo Botti | Formulations comprising cyclic compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4113739A (en) * | 1974-01-28 | 1978-09-12 | The Dow Chemical Company | Process for preparation of (poly)cyclic polyethers |
| US4474963A (en) * | 1980-11-03 | 1984-10-02 | W. R. Grace & Co. | Crown ether compositions with sidearms affording enhanced cation binding |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| CA2658039A1 (en) | 1995-09-21 | 1997-03-27 | Genentech, Inc. | Human growth hormone variants |
-
2009
- 2009-11-25 EP EP09014693A patent/EP2332929A1/en not_active Withdrawn
-
2010
- 2010-11-25 WO PCT/EP2010/068224 patent/WO2011064300A1/en not_active Ceased
- 2010-11-25 AU AU2010323101A patent/AU2010323101B2/en not_active Ceased
- 2010-11-25 CA CA2783306A patent/CA2783306C/en active Active
- 2010-11-25 JP JP2012540429A patent/JP5848708B2/ja not_active Expired - Fee Related
- 2010-11-25 CN CN201080062354.9A patent/CN102770421B/zh not_active Expired - Fee Related
- 2010-11-25 EP EP10784504.2A patent/EP2504327B1/en not_active Not-in-force
- 2010-11-25 ES ES10784504.2T patent/ES2557916T3/es active Active
- 2010-11-25 BR BR112012012539A patent/BR112012012539B8/pt not_active IP Right Cessation
- 2010-11-25 US US13/511,837 patent/US8624044B2/en not_active Expired - Fee Related
-
2012
- 2012-05-23 IL IL219966A patent/IL219966A/en active IP Right Grant
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1905454A1 (en) * | 2006-09-27 | 2008-04-02 | Paolo Botti | Formulations comprising cyclic compounds |
Non-Patent Citations (1)
| Title |
|---|
| PbOH+-selective membrane electrode based on crown ethers;Wolfgang Hasse et al.;《Sensors and Actuators B: Chemical》;19941231;第19卷;383-386 * |
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012012539A2 (pt) | 2016-05-03 |
| CA2783306C (en) | 2021-01-19 |
| AU2010323101A1 (en) | 2012-06-07 |
| IL219966A (en) | 2014-12-31 |
| BR112012012539B1 (pt) | 2021-05-11 |
| WO2011064300A1 (en) | 2011-06-03 |
| BR112012012539B8 (pt) | 2021-05-25 |
| US20120301401A1 (en) | 2012-11-29 |
| CN102770421A (zh) | 2012-11-07 |
| JP5848708B2 (ja) | 2016-01-27 |
| EP2504327B1 (en) | 2015-07-29 |
| CA2783306A1 (en) | 2011-06-03 |
| US8624044B2 (en) | 2014-01-07 |
| EP2504327A1 (en) | 2012-10-03 |
| EP2332929A1 (en) | 2011-06-15 |
| IL219966A0 (en) | 2012-07-31 |
| JP2013512221A (ja) | 2013-04-11 |
| AU2010323101B2 (en) | 2014-10-02 |
| ES2557916T3 (es) | 2016-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL220003A (en) | A drug release device | |
| CN101541346B (zh) | 包含环状化合物的制剂 | |
| JP5749155B2 (ja) | プロテアーゼ安定化アシル化インスリンアナログ | |
| JP6177975B2 (ja) | ポリエチレングリコールベースのアドレノメデュリンのプロドラッグおよびその使用 | |
| EA011351B1 (ru) | Полимерные реагенты, способы их получения, а также содержащие их конъюгаты и фармацевтические препараты | |
| EA024533B1 (ru) | Формы солей кислот конъюгатов полимер-лекарственное средство | |
| EA015333B1 (ru) | Композиции, содержащие конъюгаты, способы их получения и применение | |
| CN102770421B (zh) | 作为药物和诊断组合物的载体的冠醚的原酸酯衍生物 | |
| EP2391386B1 (en) | Oligomer-phenothiazine conjugates | |
| EP3697446A1 (en) | Macromolecular platform for targeting scavenger receptor a1 | |
| EP3129425B1 (en) | Polymer-based hydrotropes for hydrophobic drug delivery | |
| AU2006206166A1 (en) | Method of conjugating aminothiol containing molecules a polymer | |
| WO2024079348A1 (en) | Novel ionizable lipids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180919 Address after: Belgian rum Patentee after: Cape Suzhe Belgian Limited by Share Ltd. Address before: Geneva, Switzerland Patentee before: Paul Botty Effective date of registration: 20180919 Address after: Geneva, Switzerland Patentee after: Paul Botty Address before: Prams Batas, Switzerland Patentee before: ARISGEN S.A. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141126 |